510(k) Report

FDA applicant

Semperit Investments Asia Pte, Ltd.

Singapore, SG4 decisions2017–20230 recalls

FDA records 4 decisions for Semperit Investments Asia Pte, Ltd. (Singapore, SG) from 2017 to 2023: 4 510(k) clearances. Most are in product codes LZA (Polymer Patient Examination Glove) and KGO (Surgeon'S Gloves). Since 2016 its 510(k)s took a median of 212 days from receipt to decision, against 118 for FDA’s reviews in the same codes and years. Its devices cite 4 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Semperit Investments Asia Pte, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2017: 22019: 12023: 1
2017high 2 (2017) · low 0 (2018)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2017.

FIG. 1 — Semperit Investments Asia Pte, Ltd. by year, 2017–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Semperit Investments Asia Pte, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Semperit”

FDA records each applicant name separately; these may or may not be the same firm.